loading
Schlusskurs vom Vortag:
$24.66
Offen:
$24.36
24-Stunden-Volumen:
122.02K
Relative Volume:
0.25
Marktkapitalisierung:
$1.15B
Einnahmen:
$722.68M
Nettoeinkommen (Verlust:
$134.71M
KGV:
9.3071
EPS:
2.67
Netto-Cashflow:
$109.94M
1W Leistung:
+1.39%
1M Leistung:
-6.72%
6M Leistung:
+1.84%
1J Leistung:
-50.80%
1-Tages-Spanne:
Value
$24.24
$25.13
1-Wochen-Bereich:
Value
$23.77
$25.13
52-Wochen-Spanne:
Value
$20.39
$53.95

Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile

Name
Firmenname
Amphastar Pharmaceuticals Inc
Name
Telefon
909-980-9484
Name
Adresse
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Name
Mitarbeiter
2,028
Name
Twitter
Name
Nächster Verdiensttermin
2024-12-06
Name
Neueste SEC-Einreichungen
Name
AMPH's Discussions on Twitter

Vergleichen Sie AMPH mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
AMPH
Amphastar Pharmaceuticals Inc
24.84 1.15B 722.68M 134.71M 109.94M 2.67
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
142.89 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.42 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.245 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.11 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
447.46 19.53B 3.08B 1.24B 1.07B 25.61

Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-12 Hochstufung Needham Hold → Buy
2025-05-12 Herabstufung JP Morgan Overweight → Neutral
2025-02-04 Herabstufung Piper Sandler Overweight → Neutral
2024-11-22 Eingeleitet Wells Fargo Equal Weight
2024-03-05 Eingeleitet JP Morgan Overweight
2023-11-17 Eingeleitet BofA Securities Neutral
2023-07-25 Fortgesetzt Jefferies Buy
2022-10-21 Fortgesetzt Jefferies Buy
2022-07-29 Eingeleitet CapitalOne Overweight
2022-01-07 Hochstufung Piper Sandler Neutral → Overweight
2021-01-08 Herabstufung Wells Fargo Overweight → Equal Weight
2020-10-05 Hochstufung Northland Capital Market Perform → Outperform
2020-05-01 Eingeleitet Northland Capital Outperform
2019-03-13 Herabstufung Needham Buy → Hold
2019-03-13 Herabstufung Piper Jaffray Overweight → Neutral
2018-08-10 Bestätigt Needham Buy
2018-03-13 Bestätigt Needham Buy
2017-12-01 Bestätigt Needham Buy
2017-11-09 Herabstufung Raymond James Outperform → Mkt Perform
2017-09-27 Bestätigt Needham Buy
2017-03-14 Herabstufung Raymond James Strong Buy → Outperform
2016-08-09 Bestätigt Needham Buy
2016-05-10 Bestätigt Needham Buy
2016-02-19 Eingeleitet Wells Fargo Outperform
2015-06-19 Bestätigt Needham Buy
2015-06-03 Eingeleitet Raymond James Strong Buy
2014-07-21 Eingeleitet Needham Buy
Alle ansehen

Amphastar Pharmaceuticals Inc Aktie (AMPH) Neueste Nachrichten

pulisher
05:47 AM

Will Amphastar Pharmaceuticals Inc. stock deliver shareholder valueJuly 2025 Retail & Capital Efficiency Focused Ideas - newser.com

05:47 AM
pulisher
05:43 AM

Real time scanner hits for Amphastar Pharmaceuticals Inc. explainedWeekly Market Report & AI Forecasted Entry/Exit Points - newser.com

05:43 AM
pulisher
05:31 AM

Why Amphastar Pharmaceuticals Inc. (29A) stock could be next leader2025 Investor Takeaways & Short-Term Trading Alerts - newser.com

05:31 AM
pulisher
05:29 AM

Analyzing recovery setups for Amphastar Pharmaceuticals Inc. investorsJuly 2025 Price Swings & Free Expert Approved Momentum Trade Ideas - newser.com

05:29 AM
pulisher
05:20 AM

Using Python tools to backtest Amphastar Pharmaceuticals Inc. strategiesInsider Selling & Real-Time Stock Movement Alerts - newser.com

05:20 AM
pulisher
05:00 AM

Will Amphastar Pharmaceuticals Inc. (29A) stock outperform energy sector in 2025July 2025 Decliners & Target Return Focused Picks - newser.com

05:00 AM
pulisher
04:52 AM

Can trapped investors hope for a rebound in Amphastar Pharmaceuticals Inc.Portfolio Update Summary & Reliable Intraday Trade Plans - newser.com

04:52 AM
pulisher
04:06 AM

Can Amphastar Pharmaceuticals Inc. stock maintain growth trajectoryQuarterly Market Summary & Free High Accuracy Swing Entry Alerts - newser.com

04:06 AM
pulisher
03:20 AM

Should you wait for a breakout in Amphastar Pharmaceuticals Inc.2025 Stock Rankings & Daily Entry Point Trade Alerts - newser.com

03:20 AM
pulisher
03:04 AM

Can Amphastar Pharmaceuticals Inc. stock hit analyst price targetsProduct Launch & Fast Entry Momentum Alerts - newser.com

03:04 AM
pulisher
12:56 PM

Key metrics from Amphastar Pharmaceuticals Inc.’s quarterly data2025 Analyst Calls & Fast Moving Market Watchlists - newser.com

12:56 PM
pulisher
12:29 PM

Why Amphastar Pharmaceuticals Inc. stock remains resilientJuly 2025 Institutional & Real-Time Chart Pattern Alerts - newser.com

12:29 PM
pulisher
Oct 30, 2025

How Amphastar’s New BAQSIMI Distribution Pact in Greater China Could Impact AMPH Investors - Yahoo Finance

Oct 30, 2025
pulisher
Oct 30, 2025

Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Oct 30, 2025
pulisher
Oct 30, 2025

Is Amphastar Pharmaceuticals Inc. (29A) stock trading at attractive multiplesJuly 2025 Catalysts & Community Verified Swing Trade Signals - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

What momentum shifts mean for Amphastar Pharmaceuticals Inc.Weekly Profit Summary & AI Optimized Trade Strategies - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Multi asset correlation models including Amphastar Pharmaceuticals Inc.Dollar Strength & Weekly Top Performers Watchlists - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Is Amphastar Pharmaceuticals Inc. (29A) stock a buy for dividend portfoliosPortfolio Return Report & Low Risk High Win Rate Picks - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

United States Anaphylaxis Treatment Market 2025: Industry - openPR.com

Oct 29, 2025
pulisher
Oct 29, 2025

Applying Elliott Wave Theory to Amphastar Pharmaceuticals Inc.July 2025 Earnings & Precise Buy Zone Identification - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Why Amphastar Pharmaceuticals Inc. stock attracts high net worth investorsWatch List & Safe Entry Trade Reports - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Amphastar Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo

Oct 28, 2025
pulisher
Oct 28, 2025

AlphaQuest LLC Acquires 17,289 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Will Amphastar Pharmaceuticals Inc. (29A) stock beat international competitionWeekly Loss Report & Free Low Drawdown Momentum Trade Ideas - newser.com

Oct 28, 2025

Finanzdaten der Amphastar Pharmaceuticals Inc-Aktie (AMPH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$46.78
price up icon 6.04%
drug_manufacturers_specialty_generic RDY
$13.30
price down icon 1.11%
$22.73
price up icon 0.69%
$10.38
price up icon 0.25%
$140.26
price up icon 1.07%
$447.88
price down icon 1.24%
Kapitalisierung:     |  Volumen (24h):